Workflow
Augmedix(AUGX)
icon
Search documents
Augmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 List
Newsfilter· 2024-04-25 20:05
SAN FRANCISCO, April 25, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, has been named on Newsweek's list of The World's Best Digital Health Companies 2024. This prestigious award was presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. The list of awardees was unveiled on April 24th, 2024, and is available on the Newsweek website. Augmedix's inclusion highlights its commitment to empowe ...
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Newsfilter· 2024-04-24 11:00
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry's first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (NYSE:HCA), one of the nation's leading healthcare providers. ...
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
Newsfilter· 2024-04-09 11:00
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care. The alliance aims to harness the power of ambient documentation to transform the clinician-patient interaction ...
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
Newsfilter· 2024-04-04 11:00
SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an Insight company, a leading cloud business and technology consultancy. The collaboration is focused on leveraging the companies' combined technology expertise and expanding their reach to provide greater product and service value to health systems seeking high-quality ambient documentation and structured data prod ...
Augmedix(AUGX) - 2023 Q4 - Annual Report
2024-03-26 21:16
Product and Technology - Augmedix's technology aims to automate medical note creation, combining AI technologies such as speech-to-text, natural language processing, and large language models[29]. - Augmedix's open ecosystem of digital health solutions provides real-time point-of-care notifications and transforms unstructured data into structured data for health systems[26]. - The technology platform is HIPAA compliant, utilizing AI technologies such as speech-to-text and natural language processing to facilitate medical note creation[71]. - The integration of AI/ML into the technology platform aims to improve note-taking efficiency and accuracy through automated suggestions[120]. - The company has built EHR adapters for integration with major EHR providers, including Epic, Cerner, Meditech, and iKnowMed, which account for 80% of physicians served[77][88]. - The company is developing direct integration with major EHR systems to enhance operational efficiency and inform machine learning models[128]. - The company maintains a database of de-identified data to train AI models, enhancing product automation and efficiency[78]. Market and Customer Base - The company serves nearly 1.1 million physicians in the U.S., effectively covering almost every specialty with their expanded product portfolio[36]. - The anticipated market penetration for Augmedix Live is expected to cater to approximately 5-10% of the U.S. clinician market, while Augmedix Go could serve up to 85%[37]. - The total addressable market in the United States is approximately $8.0 billion annually, with existing enterprise customers representing about 20% of this market, equating to $1.6 billion[38]. - Approximately 85% of the physicians served are from large health systems, with one client accounting for 27% of clinicians in service[88]. - The company is exploring products for nurses and other healthcare professionals to further expand its total addressable market[40]. Financial Performance - For the year ended December 31, 2023, Augmedix, Inc. reported revenues of $44.855 million, an increase of 45% compared to $30.933 million in 2022[363]. - The gross profit for 2023 was $21.526 million, representing a gross margin of approximately 48%[363]. - The net loss for 2023 was $19.171 million, a decrease from a net loss of $24.449 million in 2022, indicating improved financial performance[363]. - The total cash, cash equivalents, and restricted cash increased to $46.342 million as of December 31, 2023, compared to $21.988 million at the end of 2022, representing a 110% increase[370]. - The accumulated deficit as of December 31, 2023, was $144.962 million, reflecting the ongoing financial challenges faced by the company[373]. - The company expects to continue incurring losses and negative cash flows primarily due to ongoing research, development, and marketing efforts[376]. Operational Efficiency - The company estimates that up to one-third of a doctor's day is consumed by interactions with electronic health record systems, which their solutions aim to alleviate[34]. - Clinicians spend approximately one-third of their day on non-revenue generating documentation activities, which the company's products aim to reduce, potentially saving up to three hours per day[41]. - The company's products can increase productivity by up to 20% and improve clinician satisfaction with work-life balance by 49%[43]. - The Augmedix Live service allows MDSs to assist clinicians in real-time, significantly improving work-life balance and productivity, as evidenced by case studies showing clinicians seeing 15% more patients[91][95]. - Time spent on charting reduced from 2-3 hours to just 30-45 minutes daily, allowing for better work-life balance[103]. Competition and Market Challenges - The company faces competition from larger firms and new entrants utilizing large language models, which may impact growth and customer retention[16]. - The COVID-19 pandemic accelerated the adoption of remote documentation solutions, highlighting the limitations of in-person scribing[28]. Employee and Operational Structure - The company employed a total of 1,430 full-time employees across the United States, India, and Bangladesh as of December 31, 2023[135]. - The MDS training program takes approximately three months, ensuring high-quality service delivery across various specialties[81]. - The company has implemented safeguards to comply with HIPAA and other regulations, ensuring the protection of patient health information[114]. Sales and Marketing - The company signed a marketing partnership with Google in 2022, leading to the acquisition of two new health systems, including one of the ten largest in the US[119]. - Augmedix's direct sales force focuses on acquiring new health systems and generating transactional sales, with a typical implementation window of 30-45 days[117]. - The company aims to expand its sales team following a November 2023 equity raise to target new health systems and large physician groups[64]. Intellectual Property and Compliance - Augmedix has a patent portfolio consisting of one patent and two pending applications in the United States, indicating ongoing investment in intellectual property[130]. - The company has obtained trademark protection for its brand in the United States and India, enhancing its market presence[131]. - The company aims to pursue additional intellectual property protection as deemed beneficial and cost-effective[132].
Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Seeking Alpha· 2024-03-24 04:50
ljubaphoto/E+ via Getty Images Augmedix (NASDAQ:AUGX) is a company developing AI-driven medical documentation platform for hospital and physicians Share performance has been underwhelming since going public in 2021 at the price of $5. All-time return stands at -15% today, with the stock most recently trading at $4.3. The weak all-time return is partially driven by the lackluster performance YTD. Having reached $5.8 at the start of the year in January, share price has continued to trend down since. AUGX ...
Augmedix(AUGX) - 2023 Q4 - Earnings Call Presentation
2024-03-19 03:06
Investor Presentation Nasdaq: AUGX March 2024 ...
Augmedix(AUGX) - 2023 Q4 - Earnings Call Transcript
2024-03-19 03:05
Augmedix, Inc. (NASDAQ:AUGX) Q4 2023 Earnings Conference Call March 18, 2024 4:30 PM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Elizabeth Anderson - Evercore Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group Yuan Zhi - B. Riley Securities William Sutherland - The Benchmark Company Operator Greetings and welcome to Augmedix's Fourth Quart ...
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
Newsfilter· 2024-03-18 20:01
SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. "The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially," stated Augmedix CEO Manny Krakaris. "We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in service and n ...
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
Newsfilter· 2024-03-12 11:00
SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced new positive data and product enhancements for Augmedix Go, its ambient AI medical documentation product. Now supporting over 50 medical specialties, the Augmedix Go mobile app optimizes ambient AI technology to produce comprehensive draft medical notes in real time by processing the natural conversations between clinicians and patients. New data from sur ...